A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Non ancora tradotto Non ancora tradotto
Autori
Categoria Primary study
Registry of TrialsClinicalTrials.gov
Year 2011

This article is not included in any systematic review

This article is part of the following publication threads:
Loading references information
This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in patients with moderate to severe ulcerative colitis who have failed or be intolerant to one of following treatments for ulcerative colitis: oral steroids, azathiopurine/6-mercaptopurine, or anti-TNF-alpha therapy.
Epistemonikos ID: 5f8fb660039c0715608d558e2e3a78d30eaf57fd
First added on: Mar 23, 2022